Douglas B. Snyder
Chief Legal OfficerMr. Douglas B. Snyder, also known as Doug, is Chief Legal Officer of IDEAYA Biosciences, Inc. since January 2026 and served as Senior Vice President & General Counsel from September 18, 2024 to January 2026. Mr. Snyder has been Chief Legal Officer at GW Pharmaceuticals plc since July 2017 and serves as its Secretary. Mr. Snyder served as Vice President, General Counsel and Secretary of Eisai Inc. since August 2005 and served as its Senior Vice President, where he led the Legal, Compliance, Legislative Affairs, Internal Audit and Security Group. Mr. Snyder served as Senior Vice President, General Counsel and Secretary of Actelion Pharmaceuticals US, Inc. He led the legal and compliance teams at Actelion U.S., a pharmaceuticals and biotechnology company. He was associated with GlaxoSmithKline (GSK) where he served as Vice President and Associate General Counsel from 1999 to 2005. During his tenure at GSK, Mr. Snyder managed the legal and communications strategies related to some of GSK’s most high-profile matters concerning the New York Attorney General, the U.S. Department of Justice and the FDA. His responsibilities included legal services for sales and marketing, research and development, manufacturing and other functions as well as management of litigation, contract and regulatory activities. Before joining the pharmaceutical industry, he held the role of Associate General Counsel for the FDA where he counseled the Commissioner, appeared before Congress in key initiatives and led the initial False Claims/Kickback cases against the pharmaceutical industry. He has many years of experience providing counsel in the pharmaceutical industry, at the U.S. Food and Drug Administration (“FDA”) and in private practice. Mr. Snyder holds a J.D. from the Catholic University of America, Columbus School of Law and a B.A. from Dickinson College.
Positions
- Company NameIDEAYA Biosciences, Inc.Stock CodeIDYAPositionChief Legal OfficerColleagues
- YSYujiro S. HataFounder, President, CEO & Chairman
- JBJoshua BleharskiChief Financial Officer
- ARAndres Ruiz BrisenoChief Accounting Officer
- MAMichael A. WhitePresident of Research & Development
- JLJeffrey L. SteinIndependent Director
- SWScott William MorrisonIndependent Director
- FPFrank P. McCormickChair of Scientific Advisory Board
- TJTerry J. RosenLead Independent Director
